Materials • Major Chemicals
$1.70 ▲ +0.05
(+3.03%)
MKT CAP: $16.6M • VOL: 11.3K
52W L $1 52W H $3
ROARABLE / RQD
D • 44/100
PIOTROSKI
4 / 9
TOMZ // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.6M | $7.7M | $7.4M |
| YoY Revenue Growth % | -27.2% | +5.2% | — |
| Gross Profit | $3.1M | $3.6M | — |
| Gross Margin % | 54.6% | 46.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$3.9M | -$4.1M | -$3.3M |
| Operating Margin % | -68.4% | -53.0% | -45.5% |
| Net Income (GAAP) | -$3.7M | -$4.5M | -$3.4M |
| EBITDA (Normalized) | -$3.9M | -$4.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$1.2M | -$1.4M | -$3.6M |
| Capital Expenditures (CapEx) | $5.2K | $107.9K | — |
| Free Cash Flow (FCF) | -$1.2M | -$1.5M | -$3.6M |
| FCF Margin % | -21.3% | -20.0% | -48.9% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | — | $88.0K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $588.5K | $4.1M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR TOMZ.